ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconFacebook IconIcon FacebookGoogle Plus IconLayer 1InstagramCreated with Sketch.Linkedin IconIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintRSS IconIcon SearchSite TitleTitle ChevronTwitter IconIcon TwitterYoutube Icon
Health Technology

Olympus Corp.

  • 4,430.00 JPY
  • -20.00
  • -0.45%
  • Japan
    Jul 18, 2018
  • Ticker
    TKS(7733)
  • Prev. close
    4,450
  • Market cap (JPY)
    1,524.97B
  • Market cap (USD)
    13,515.09M
  • Shares
    342.69M

Business Summary

Olympus Corp. is engaged in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical Systems, Life Sciences and Industrial, Imaging Systems, Information and Communications, and Others. The Medical Systems segment covers endoscopes, and endoscopic surgery and therapy. The Life Sciences and Industrial segment manufactures and sells biological and industrial microscopes, industrial endoscopes, non-destructive testing equipment, and printers. The Imaging Systems segment deals with digital cameras and recording devices. The Information and Communication segment sells mobile terminals such as mobile phones. The Others segment includes biomaterial manufacturing and sales, and system development. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2018 JPYUSD
Revenue786,497M7,096.27M
Gross Profit481,111M4,340.88M
Operating income84,282M760.44M
Income before tax76,665M691.71M
Net income57,064M514.86M
EBITDA137,195M1,237.85M
Diluted EPS166.761.50
Dividends Per Share280.25
Total Assets978,663M9,202.28M
Total liabilities534,404M5,024.95M
Total equity442,793M4,163.54M
Operating cash flow95,146M858.46M
Currency in JPYCurrency in USD

Historical Data

 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 713,286M 764,671M 804,578M 740,557M 786,497M
Gross Profit 442,623M 489,040M 534,482M 447,567M 481,111M
Operating income 73,445M 91,712M 104,464M 80,789M 84,282M
Income before tax 16,425M 8,934M 70,800M 62,481M 76,665M
Net income 13,627M -8,737M 62,594M 42,783M 57,064M
EBITDA 119,752M 142,352M 154,243M 135,079M 137,195M
Diluted EPS 41.04 -25.53 182.84 124.96 166.76
Dividends Per Share 0 10 17 28 28
Total Assets 1,027.47B 1,081.55B 1,000.61B 960,032M 978,663M
Total liabilities 696,191M 724,297M 616,331M 563,804M 534,404M
Total equity 329,634M 355,722M 382,787M 394,751M 442,793M
Operating cash flow 72,388M 66,811M 48,621M 102,052M 95,146M
 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 7,120.64M 6,960.63M 6,700.11M 6,838.80M 7,096.27M
Gross Profit 4,418.65M 4,451.62M 4,450.89M 4,133.13M 4,340.88M
Operating income 733.19M 834.83M 869.92M 746.06M 760.44M
Income before tax 163.96M 81.32M 589.58M 576.99M 691.71M
Net income 136.03M -79.53M 521.25M 395.08M 514.86M
EBITDA 1,195.46M 1,295.79M 1,284.45M 1,247.41M 1,237.85M
Diluted EPS 0.40 -0.23 1.52 1.15 1.50
Dividends Per Share 0 0.09 0.14 0.25 0.25
Total Assets 9,976.93M 9,018.56M 8,902.65M 8,615.56M 9,202.28M
Total liabilities 6,760.12M 6,039.58M 5,483.61M 5,059.71M 5,024.95M
Total equity 3,200.79M 2,966.20M 3,405.72M 3,542.59M 4,163.54M
Operating cash flow 722.64M 608.16M 404.89M 942.41M 858.46M

Valuation Measures

Mar 2018
PER24.21
ROA5.88%
ROE13.62%
Operating margin10.71%
Profit margin7.25%

Key executives

  • Executive President & Representative Director: Hiroyuki Sasa
  • Chief Financial Officer, Director & Executive VP: Yasuo Takeuchi
  • Director & Chief Technology Officer: Haruo Ogawa
  • Global Chief Compliance Officer: Caroline West
  • Executive Officer: Hitoshi Kawada

Shareholders

  • Harris Associates LP (5.2%)
  • ValueAct Capital Management LP (5.0%)
  • Sony Corp. (5.0%)
  • Nomura Asset Management Co., Ltd. (4.4%)
  • Northern Cross LLC (4.1%)
  • Nippon Life Insurance Co. (3.8%)
  • Asset Management One Co., Ltd. (3.3%)
  • Mitsubishi UFJ Financial Group, Inc. (3.2%)
  • BlackRock Fund Advisors (2.3%)
  • Nikko Asset Management Co., Ltd. (2.1%)

Contact Details

  • Website:http://www.olympus.co.jp
  • Address: Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Tokyo, 163-0914, Japan
  • Phone: +81.3.3340.2111

Related Companies

  • Olympus Restricted Stock Compensation Plan
  • Olympus NDT Systems, Inc.
  • YuanLi Instrument Co. Ltd.
  • Olympus Service Facility Portugal - Tecnologias Opticas e Digi
  • Olympus Korea Service Co., Ltd.
  • Olympus Optical do Brasil Ltda.
  • Olympus Moscow LLC
  • Olympus Europa SE & Co. KG
  • Olympus Europa Property Management GmbH
  • Olympus doo za trgovinu
  • Olympus Corporation of the Americas Pennsylvania
  • Olympus doo Beograd
  • Olympus Czech Group sro
  • Olympus Slovenija Trgovina doo
  • Olympus Iberia SAU
  • Olympus Communications Technology of America, Inc.
  • Vichen B&I Co., Ltd.
  • Gyrus ACMI, Inc.
  • Olympus Estonia OU
  • Olympus (Thailand) Co. Ltd.
  • Olympus Australia Pty Ltd.
  • Olympus Europa Management SE
  • Olympus BH doo
  • Olympus Medical Systems Vietnam Co. Ltd.
  • Olympus Schweiz AG
  • Olympus Canada, Inc.
  • Olympus Scientific Solutions Americas, Inc.
  • Olympus (Guangzhou) Industrial Ltd.
  • Olympus Lithuania UAB
  • Olympus Latvia SIA

Competitors

  • Stryker Corporation
  • Johnson & Johnson
  • Boston Scientific Corporation
  • Medtronic plc
  • Panasonic Corporation
  • Sony Corporation
  • Canon Inc.
  • General Electric Company
  • FUJIFILM Holdings Corp
  • Danaher Corporation
  • HOYA CORPORATION
  • Nikon Corp.
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Carl Zeiss Meditec AG
  • CONMED Corporation
  • Mauna Kea Technologies SA Class O
  • Merit Medical Systems, Inc.
  • Intuitive Surgical, Inc.
  • Cantel Medical Corp.
  • Cooper Companies, Inc.
  • GoPro, Inc. Class A
  • STERIS Plc
  • Motus GI Holdings, Inc.
  • TSO3 Inc.
  • Microbot Medical Inc
  • Check-Cap Ltd.
  • Kinko Optical Co. Ltd.
  • Dextera Surgical, Inc.
  • Bruker Corporation
Last Updated on 18 Jul, 2018

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

3 months for $9

Get unlimited access
NAR site on phone, device, tablet

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media